Download PDF
Dtsch Med Wochenschr 2009; 134(20): 1061
DOI: 10.1055/s-0029-1222569
Pro & Contra | Commentary
Diabetologie, Kardiologie
© Georg Thieme Verlag KG Stuttgart · New York

Intensive Blutglukosesenkung zur Reduktion des kardiovaskulären Risikos: contra

Intensive glucose lowering to reduce cardiovascular risk: contraN. Marx1
  • 1Klinik für Innere Medizin II, Medizinische Universitätsklinik Ulm
Further Information

Publication History

Publication Date:
06 May 2009 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Blutglukosesenkung - kardiovaskuläres Risiko

Keywords

blood glucose control - cardiovascular risk

Literatur

  • 1 Dluhy R G, McMahon G T. Intensive glycemic control in the ACCORD and ADVANCE trials.  N Engl J Med. 2008;  358 (24) 2630-2633
    Google Scholar
  • 2 Gaede P, Lund-Andersen H, Parving H H. et al . Effect of a multifactorial intervention on mortality in type 2 diabetes.  N Engl J Med. 2008;  358 (6) 580-591
    Google Scholar
  • 3 Gaede P, Vedel P, Larsen N. et al . Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.  N Engl J Med. 2003;  348 (5) 383-393
    Google Scholar
  • 4 Gerstein H C, Miller M E, Byington R P. et al . Effects of intensive glucose lowering in type 2 diabetes.  N Engl J Med. 2008;  358 (24) 2545-2559
    Google Scholar
  • 5 Patel A, MacMahon S, Chalmers J. et al . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.  N Engl J Med. 2008;  358 (24) 2560-2572
    Google Scholar
  • 6 UKPDS . Intensive blood-glucose control with sulfonureas or insulin compared with conventional treatment and risk of complications in patients with type II diabetes.  Lancet. 1998;  352 837-853
    Google Scholar

Prof. Dr. med. Nikolaus Marx

Klinik für Innere Medizin II, Medizinische Universitätsklinik Ulm

Albert-Einstein-Allee 23

89081 Ulm

Phone: 0731/500-45001 oder -45024

Fax: 0731/500-45025

Email: nikolaus.marx@uniklinik-ulm.de

      >